Aieop: Associazione Italiana Ematologia Oncologia Pediatrica company information, Employees & Contact Information

8th International Symposium on Childhood, AYA Non-Hodgkin Lymphoma – AIEOP Oncodaily

Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial Wiley Online Library

Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration ASCO Publications

Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age Frontiers

Invasive fungal diseases impact on outcome of childhood ALL – an analysis of the international trial AIEOP-BFM ALL 2009 Nature

Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job’s syndrome Allergy, Asthma & Clinical Immunology

Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial ScienceDirect.com

AIEOP’s new 2024-2027 Board of Directors Oncodaily

Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy Frontiers

Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009 Wiley Online Library

Call For Abstracts for AIEOP’s 2025 National Congress Oncodaily

“CHildren with Inherited Platelet disorders Surveillance” (CHIPS) retrospective and prospective observational cohort study by Italian Association of Pediatric Hematology and Oncology (AIEOP) Frontiers

50th AIEOP National Congress – Timetable Is Here! Oncodaily

Introducing AIEOP’S 2024-2027 Working Group Coordinators – Simone Cesaro Oncodaily

​Giornate AIEOP 2025: Advancing Pediatric Hematology and Oncology​ Oncodaily

Introducing the Coordinators of AIEOP’s 2024-2027 Working Groups – Marta Pillon Oncodaily

AIEOP’s Board of Directors activities report 2021-2024 Oncodaily

Highlights From The AIEOP 2024 Congress Oncodaily

Therapeutic Update: Nimotuzumab and Vinorelbine for Midline Gliomas – AIEOP Oncodaily

Diagnosis and management of neutropenia in children: The approach of the Study Group on Neutropenia and Marrow Failure Syndromes of the Pediatric Italian Hemato-Oncology Association (Associazione Italiana Emato-Oncologia Pediatrica - AIEOP) Wiley Online Library

SIOPE Course in Paediatric Oncology 2025-2027 is open for Applications – AIEOP Oncodaily

Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study Haematologica

Primary Immunodeficiencies and Oncological Risk: The Experience of the Children's Hospital of Brescia Frontiers

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial Nature

Open issues in Mucopolysaccharidosis type I-Hurler Orphanet Journal of Rare Diseases

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience Orphanet Journal of Rare Diseases

SETIL: Italian multicentric epidemiological case–control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in Italy Italian Journal of Pediatrics

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia Nature

Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols Nature

Modulation of antigen expression in B-cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug-induced regulatory phenomenon. Results of the AIEOP-BFM-ALL-FLOW-MRD-Study Group Wiley Online Library

GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute researchgate.net